Exchange: OTC·Updated 01:14 PM EDT

SYRS Syros Pharmaceuticals Inc.

$0.0001
$0.00
(0.00%)
Today
Reported EarningsOct 31
Mkt Cap$2,683.00
Vol4,495.00

About SYRS

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.
61

Bullish Sentiment

How do you feel about SYRS?

Advertisement|Remove ads.